Targeted destruction of androgen-sensitive and -insensitive prostate cancer cells and xenografts through luteinizing hormone receptors

Prostate

Volumn 46, Issue 2, 2001, Pages 116-125

  Leuschner, Carola ^a   Enright, Frederick M ^b   Melrose, Patricia A ^b   Hansel, William ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

LH receptor; Lytic peptide conjugate; Prostate cancer; Steroids

Indexed keywords

AMINO ACID; ANDROGEN; EPIDERMAL GROWTH FACTOR; FOLLITROPIN; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR; PEPTIDE HORMONE;

ANDROGEN BLOOD LEVEL; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CANCER CELL CULTURE; CHO CELL; HORMONE SENSITIVITY; LUTEINIZING HORMONE BLOOD LEVEL; MALE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE CANCER; RECEPTOR BINDING; STEROID BLOOD LEVEL; TARGET CELL; XENOGRAFT;

AMINO ACID SEQUENCE; ANIMALS; CHARCOAL; CHO CELLS; CRICETINAE; DRUG CARRIERS; EPIDERMAL GROWTH FACTOR; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; MALE; MELITTEN; MICE; MICE, INBRED BALB C; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASMS, HORMONE-DEPENDENT; PEPTIDE FRAGMENTS; PROSTATIC NEOPLASMS; RECEPTORS, LH; TRANSFECTION; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035253465     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0045(20010201)46:2<116::AID-PROS1015>3.0.CO;2-B     Document Type: Article

References (22)

1. Endocrine therapy in carcinoma of the prostate gland: 10-year survival studies
2. Hormonal regulation of luteinizing hormone/chorionic gonadotropin receptor mRNA in rat ovarian cells during follicular development and luteinization
3. A role of increased lutropin/choriogonadotropin receptor LHR gene transcription in the follitropin stimulated induction of the LHR in granulosa cells
4. Epidermal growth factor, a phorbol ester, and 3′,5′-cyclic adenosine monophosphate decrease the transcription of the luteinizing hormone/chorionic gonadotropin receptor gene in MA-10 Leydig tumor cells
5. Structure activity studies on magainins and other host defense peptides
6. The action of melittin on membranes
7. A receptor binding site identified in the region 81-95 of the beta-subunit of human luteinizing hormone (LH) and chorionic gonadotropin (hCG)
8. Expression of luteinizing hormone/human chorionic gonadotropin receptor gene in benign prostatic hyperplasia and in prostate carcinoma in humans
9. Coexpression of gonadotropic hormones and their corresponding FSH and LH/CG receptors in the human prostate
10. Expression and functionality of luteinizing hormone/chorionic gonadotropin receptor in the rat prostate
11. Co-evolution of ligand-receptor pairs
12. Receptors for luteinizing hormone-releasing hormone (LHRH) in Dunning R 3327 prostate cancers and rat anterior pituitaries after treatment with a sustained delivery system of LHRH antagonist SB-75
13. Protein measurement with the Folin phenol reagent
14. Human prostate tumor angiogenesis in nude mice: Metalloprotease and plasminogen activator activities during tumor growth and neovascularization of subcutaneously injected matrigel impregnated with human prostate tumor cells
15. Receptor mediated endocytosis of epidermal growth factor
16. Arachidonic acid release from rat Leydig cells depends on the presence of luteinizing hormone/human chorionic gonadotrophin receptors
17. Sites of interaction between epidermal growth factor and transforming growth factor beta 1 in the control of steroidogenesis in cultured porcine Leydig cells
18. Multiple estrogen function in human prostate cancer cells
19. Tamoxifen decreases cholesterol sevenfold and abolishes lipid lesion development in apolipoprotein E knockout mice
20. Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor negative breast cancer cells
21. Epidermal growth factor receptor activation in androgen independent but not androgen stimulated growth of human prostatic carcinoma cells